Your browser doesn't support javascript.
loading
Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.
Kwak, Soongu; Everett, Russell J; Treibel, Thomas A; Yang, Seokhun; Hwang, Doyeon; Ko, Taehoon; Williams, Michelle C; Bing, Rong; Singh, Trisha; Joshi, Shruti; Lee, Heesun; Lee, Whal; Kim, Yong-Jin; Chin, Calvin W L; Fukui, Miho; Al Musa, Tarique; Rigolli, Marzia; Singh, Anvesha; Tastet, Lionel; Dobson, Laura E; Wiesemann, Stephanie; Ferreira, Vanessa M; Captur, Gabriella; Lee, Sahmin; Schulz-Menger, Jeanette; Schelbert, Erik B; Clavel, Marie-Annick; Park, Sung-Ji; Rheude, Tobias; Hadamitzky, Martin; Gerber, Bernhard L; Newby, David E; Myerson, Saul G; Pibarot, Phillipe; Cavalcante, João L; McCann, Gerry P; Greenwood, John P; Moon, James C; Dweck, Marc R; Lee, Seung-Pyo.
Afiliación
  • Kwak S; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Everett RJ; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Treibel TA; Barts Health NHS Trust and University College London, London, United Kingdom.
  • Yang S; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Hwang D; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Ko T; Office of Hospital Information, Seoul National University Hospital, Seoul, Korea.
  • Williams MC; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Bing R; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Singh T; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Joshi S; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Lee H; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Lee W; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Kim YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Chin CWL; National Heart Center Singapore, Singapore.
  • Fukui M; Cardiovascular Imaging Research Center and Core Lab, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.
  • Al Musa T; Multidisciplinary Cardiovascular Research Centre & The Division of Biomedical Imaging, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Rigolli M; University of Oxford Centre for Clinical Magnetic Resonance Research, BHF Centre of Research Excellence (Oxford), NIHR Biomedical Research Centre (Oxford), Oxford, United Kingdom.
  • Singh A; Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
  • Tastet L; Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec City, Québec, Canada.
  • Dobson LE; Multidisciplinary Cardiovascular Research Centre & The Division of Biomedical Imaging, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Wiesemann S; Charité Campus Buch ECRC and Helios Clinics Cardiology Germany, DZHK partner site, Berlin, Germany.
  • Ferreira VM; University of Oxford Centre for Clinical Magnetic Resonance Research, BHF Centre of Research Excellence (Oxford), NIHR Biomedical Research Centre (Oxford), Oxford, United Kingdom.
  • Captur G; Inherited Heart Muscle Disease Clinic, Department of Cardiology, Royal Free Hospital, NHS Foundation Trust, London, United Kingdom.
  • Lee S; Division of Cardiology, Asan Medical Center Heart Institute, University of Ulsan College of Medicine, Seoul, South Korea.
  • Schulz-Menger J; Charité Campus Buch ECRC and Helios Clinics Cardiology Germany, DZHK partner site, Berlin, Germany.
  • Schelbert EB; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Clavel MA; Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec City, Québec, Canada.
  • Park SJ; Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Rheude T; Department of Cardiology, German Heart Center Munich, Munich, Germany.
  • Hadamitzky M; Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany.
  • Gerber BL; Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc and Institut de Recherche Cardiovasculaire, Université Catholique de Louvain, Brussels, Belgium.
  • Newby DE; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Myerson SG; University of Oxford Centre for Clinical Magnetic Resonance Research, BHF Centre of Research Excellence (Oxford), NIHR Biomedical Research Centre (Oxford), Oxford, United Kingdom.
  • Pibarot P; Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart and Lung Institute, Université Laval, Québec City, Québec, Canada.
  • Cavalcante JL; UPMC Cardiovascular Magnetic Resonance Center, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • McCann GP; Department of Cardiovascular Sciences, Glenfield Hospital, University of Leicester and NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom.
  • Greenwood JP; Multidisciplinary Cardiovascular Research Centre & The Division of Biomedical Imaging, Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
  • Moon JC; Barts Health NHS Trust and University College London, London, United Kingdom.
  • Dweck MR; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: marc.dweck@ed.ac.uk.
  • Lee SP; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea; Center for Precision Medicine, Seoul National University Hospital, Seoul, South Korea. Electronic address: sproll1@snu.ac.kr.
J Am Coll Cardiol ; 78(6): 545-558, 2021 08 10.
Article en En | MEDLINE | ID: mdl-34353531
ABSTRACT

BACKGROUND:

Cardiovascular magnetic resonance (CMR) is increasingly used for risk stratification in aortic stenosis (AS). However, the relative prognostic power of CMR markers and their respective thresholds remains undefined.

OBJECTIVES:

Using machine learning, the study aimed to identify prognostically important CMR markers in AS and their thresholds of mortality.

METHODS:

Patients with severe AS undergoing AVR (n = 440, derivation; n = 359, validation cohort) were prospectively enrolled across 13 international sites (median 3.8 years' follow-up). CMR was performed shortly before surgical or transcatheter AVR. A random survival forest model was built using 29 variables (13 CMR) with post-AVR death as the outcome.

RESULTS:

There were 52 deaths in the derivation cohort and 51 deaths in the validation cohort. The 4 most predictive CMR markers were extracellular volume fraction, late gadolinium enhancement, indexed left ventricular end-diastolic volume (LVEDVi), and right ventricular ejection fraction. Across the whole cohort and in asymptomatic patients, risk-adjusted predicted mortality increased strongly once extracellular volume fraction exceeded 27%, while late gadolinium enhancement >2% showed persistent high risk. Increased mortality was also observed with both large (LVEDVi >80 mL/m2) and small (LVEDVi ≤55 mL/m2) ventricles, and with high (>80%) and low (≤50%) right ventricular ejection fraction. The predictability was improved when these 4 markers were added to clinical factors (3-year C-index 0.778 vs 0.739). The prognostic thresholds and risk stratification by CMR variables were reproduced in the validation cohort.

CONCLUSIONS:

Machine learning identified myocardial fibrosis and biventricular remodeling markers as the top predictors of survival in AS and highlighted their nonlinear association with mortality. These markers may have potential in optimizing the decision of AVR.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Asunto principal: Estenosis de la Válvula Aórtica / Fibrosis / Imagen por Resonancia Cinemagnética / Implantación de Prótesis de Válvulas Cardíacas / Remodelación Ventricular / Miocardio Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Corea del Sur

Texto completo: 1 Colección: 01-internacional Asunto principal: Estenosis de la Válvula Aórtica / Fibrosis / Imagen por Resonancia Cinemagnética / Implantación de Prótesis de Válvulas Cardíacas / Remodelación Ventricular / Miocardio Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: J Am Coll Cardiol Año: 2021 Tipo del documento: Article País de afiliación: Corea del Sur